Corporate News
The latest information on our product and service enhancements, client wins and company moves.
Marcuard Family Office Using MPI’s Patented DSA
Marcuard Family Office adopts MPI’s proprietary quantitative analytics for investment decision making. Read more about the motivation for Marcuard’s adoption of DSA.
FT Profile on MPI: Helping HF Investors Raise Flags and Choose Better Managers
This FTfm profile of MPI discusses the power of MPI’s software for managing portfolios of hedge funds, including selecting superior managers, managing risk and detecting potential fraud.
Bridgewater Case Study featured in CFA Publication
MPI’s case study on Bridgewater Pure Alpha II is quoted in Tim Nuding’s article “Hedge Fund Return Expectations in a Paranormal World” in the Summer 2012 edition of Professional Investor: The Journal of the CFA Society of the UK.
MPI Launches “Chart of the Week”
Commencing a new weekly post on the Research Corner, MPI uses dynamic factor analysis to estimate exposures to Facebook in its first month of trading. Introducing, Chart of the Week: Facebook.
FTfm Article on Risk Parity Features MPI
MPI CEO Michael Markov discusses the rising popularity of risk parity and the predictable short term nature of risk in this FTfm story by Sophia Grene.
MPI Presents to EU CFA Societies on Dynamic Factor Analysis
Michael Markov spoke in Europe at a series of CFA seminars on the powers of dynamic factor analysis and its patented methodology, DSA. Please contact us to request presentation “Hidden sources of alpha: from market timing to insider trading”. See our blog post for more.
AIJ and Systemic Manager Surveillance
With the AIJ fraud rattling the Japanese Investment community, MPI CEO Michael Markov presented at Waseda University on its ex-ante analysis of the AIJ fraud and techniques for manager and fund universe surveillance. See our AIJ blog post for more.
MPI Releases New Case Study on Bridgewater Pure Alpha
MPI has released a case study which demonstrates that predictive analytic techniques can be used to mimic beta exposures of hedge funds. Access the case study here.